Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014

Regular physical activity reduces breast cancer risk irrespective of age

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Regular physical activity reduces breast cancer risk irrespective of age ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
31 Mar 2014

Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes

Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan
Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes ( Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan )
31 Mar 2014

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014

Symptom management and quality of life in metastatic breast cancer

Dr Polly Niravath - Baylor College of Medicine, Houston, Texas
Symptom management and quality of life in metastatic breast cancer ( Dr Polly Niravath - Baylor College of Medicine, Houston, Texas )
20 Dec 2013

The impact of biological age on breast cancer

Dr Alistair Ring - Brighton and Sussex Medical School, UK
The impact of biological age on breast cancer ( Dr Alistair Ring - Brighton and Sussex Medical School, UK )
20 Dec 2013

Aspirin trialled for breast cancer recurrence prevention

Dr Alistair Ring - Brighton and Sussex Medical School, UK
Aspirin trialled for breast cancer recurrence prevention ( Dr Alistair Ring - Brighton and Sussex Medical School, UK )
20 Dec 2013

Drop in breast cancer mortality in developed countries varies

Dr Donald Berry - MD Anderson Cancer Center, Houston, USA
Drop in breast cancer mortality in developed countries varies ( Dr Donald Berry - MD Anderson Cancer Center, Houston, USA )
19 Dec 2013

Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast cancer

Dr Barbara Fowble - University of California, San Francisco, USA
Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast cancer ( Dr Barbara Fowble - University of California, San Francisco, USA )
19 Dec 2013

Translational studies of CDK and PARP inhibitors

Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Translational studies of CDK and PARP inhibitors ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013

HER2 positive breast cancer treatment, past and future

Dr Edith Perez - Mayo Clinic, Rochester, USA
HER2 positive breast cancer treatment, past and future ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
19 Dec 2013

Preventing metastases by tackling exosomes

Dr Jeff Wrana - University of Toronto, Canada
Preventing metastases by tackling exosomes ( Dr Jeff Wrana - University of Toronto, Canada )
19 Dec 2013